ExpansionJul 14, 2026, 05:11 PM
Capricor Therapeutics Leases 171,000 Sq Ft for New San Diego HQ
AI Summary
Capricor Therapeutics, Inc. has entered into a lease agreement for a new 171,000 square foot headquarters in San Diego, California. The facility will include expanded manufacturing cleanrooms, research and development laboratories, and administrative offices. The lease, with an initial monthly base rent of approximately $958,000, includes significant rent abatements and a contingency for FDA approval of Deramiocel by December 31, 2026.
Key Highlights
- Capricor Therapeutics leased approximately 171,000 rentable square feet for its new San Diego headquarters.
- The initial monthly base rent is approximately $958,000, subject to annual increases of 3.0%.
- The lease term will be 138 months from the first full month following rent commencement.
- Capricor will receive an 18-month full base rent abatement, followed by a 6-month partial abatement.
- A security deposit of approximately $958,000 will be provided.
- Lease commencement is contingent on FDA approval of Deramiocel or by December 31, 2026.
Price Impact
More from CAPR